K Oberg Selected Research

K Oberg Research Topics

Disease

19	Carcinoid Tumor (Carcinoid) 08/2015 - 01/2000
17	Neoplasms (Cancer) 08/2015 - 01/2000
10	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2014 - 01/2000
2	Neoplasm Metastasis (Metastasis) 01/2006 - 09/2000
2	Lymphatic Metastasis 03/2000 - 01/2000
1	Islet Cell Carcinoma 01/2008
1	Small Cell Carcinoma 01/2008
1	Flushing 06/2004
1	Diarrhea 06/2004
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 02/2001
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 10/2000
1	Gastrinoma 03/2000
1	Insulinoma 03/2000
1	Glucagonoma 03/2000

Drug/Important Bio-Agent (IBA)

8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2015 - 03/2000
6	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2015 - 09/2000
6	Octreotide (Sandostatin)FDA LinkGeneric 06/2004 - 03/2000
6	Interferon-alpha (Interferon Alfa)IBA 01/2002 - 01/2000
5	Proteins (Proteins, Gene)FDA Link 02/2001 - 03/2000
3	Tumor Biomarkers (Tumor Markers)IBA 11/2011 - 01/2000
3	AntibodiesIBA 11/2011 - 03/2000
3	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 06/2005 - 01/2000
3	Serotonin (5 Hydroxytryptamine)IBA 08/2003 - 03/2000
3	Hormones (Hormone)IBA 10/2001 - 01/2000
2	Chromogranin AIBA 11/2011 - 01/2000
2	Peptides (Polypeptides)IBA 11/2011 - 03/2000
2	AminesIBA 11/2011 - 01/2000
2	Biomarkers (Surrogate Marker)IBA 11/2011 - 01/2000
2	Carbidopa (Lodosyn)FDA LinkGeneric 01/2006 - 03/2000
2	InterferonsIBA 06/2004 - 01/2000
2	Etoposide (VP 16)FDA LinkGeneric 10/2001 - 01/2001
1	Ma2 antigenIBA 11/2011
1	Cytostatic AgentsIBA 01/2008
1	trisacryl gelatin microspheresIBA 03/2007
1	Dihydroxyphenylalanine (Dopa)IBA 06/2005
1	RadiopharmaceuticalsIBA 06/2005
1	metomidateIBA 06/2005
1	lanreotide (Somatuline)FDA Link 06/2004
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2003
1	Monoamine Oxidase (MAO)IBA 08/2003
1	Dopamine (Intropin)FDA LinkGeneric 08/2003
1	Complementary DNA (cDNA)IBA 02/2001
1	Phospholipases (Phospholipase)IBA 02/2001
1	RNA (Ribonucleic Acid)IBA 02/2001
1	ColforsinIBA 01/2001
1	Cytotoxins (Cytolysins)IBA 01/2001
1	PTR 3173IBA 01/2001
1	somatostatin receptor 2IBA 01/2001
1	pentetreotide (OctreoScan)FDA Link 01/2001
1	Glucagon (Glukagon)FDA Link 01/2001
1	Mitotane (Lysodren)FDA Link 10/2000
1	Streptozocin (Streptozotocin)FDA Link 10/2000
1	Gastrin-Releasing PeptideIBA 09/2000
1	Cell Surface ReceptorsIBA 09/2000
1	SilverIBA 09/2000
1	PlasticsIBA 09/2000
1	Pentetic Acid (DTPA)FDA LinkGeneric 09/2000
1	AcidsIBA 09/2000
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 06/2000
1	Ribonucleases (Ribonuclease)IBA 06/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2000
1	Glucose (Dextrose)FDA LinkGeneric 03/2000
1	Protein Isoforms (Isoforms)IBA 03/2000
1	Carboxy-LyasesIBA 03/2000
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2000
1	RibonucleotidesIBA 03/2000
1	Levodopa (L Dopa)FDA LinkGeneric 03/2000
1	Messenger RNA (mRNA)IBA 03/2000
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2000
1	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 03/2000
1	EnzymesIBA 03/2000
1	Monoclonal AntibodiesIBA 03/2000
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2000

Therapy/Procedure

3	Therapeutics 03/2014 - 01/2001
3	Drug Therapy (Chemotherapy) 01/2008 - 03/2000
1	Immunotherapy 03/2014
1	Oral Administration 01/2006
1	Intravenous Injections 09/2000
1	Premedication 03/2000
1	Lasers (Laser) 03/2000
1	Radiofrequency Therapy 03/2000